Skip to main content
. 2019 Nov 13;69(Suppl 7):S529–S537. doi: 10.1093/cid/ciz825

Figure 2.

Figure 2.

Structures of the monocyclic β-lactam-siderophore conjugates that have been evaluated for clinical development—BAL30072 (terminated in phase 1), MB-1 (preclinical investigation only), MC-1 (preclinical investigation only), and SMC-3176 (preclinical investigation only).